Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-06-07 @ 3:36 PM
Study NCT ID:
NCT02624895
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2015-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line
Sponsor:
Amgen
Organization: